BioCentury | Nov 11, 2020
Product Development
Nov. 10 Quick Takes: Tezepelumab meets in asthma Phase III; plus a call for speedy trial results, updates on COVID vaccines from Sinovac, CureVac and more
...IL-12, ImmunoPulse IL-12, OMS ElectroImmunotherapy (ImmunoPulse))
Cryopraxis Cryobiology Ltd.
Merck
iRepertoire Inc.
Amgen...
